We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+8.3%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$36.4B
AUM Growth
+$3.53B
Cap. Flow
+$1.12B
Cap. Flow %
3.08%
Top 10 Hldgs %
20.83%
Holding
3,908
New
299
Increased
2,042
Reduced
1,302
Closed
193

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$67.7M
2
QQQM icon
Invesco NASDAQ 100 ETF
QQQM
+$38.1M
3
VCIT icon
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
+$24.7M
4
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
+$24.2M
5
CGGR icon
Capital Group Growth ETF
CGGR
+$21.8M

Top Sells

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$27.2M
2
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$22.4M
3
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$16.6M
4
FVD icon
First Trust Value Line Dividend Fund
FVD
+$13.3M
5
SCZ icon
iShares MSCI EAFE Small-Cap ETF
SCZ
+$13.1M

Sector Composition

Rank Sector Weight
1 Technology 12.56%
2 Financials 4.99%
3 Consumer Discretionary 3.69%
4 Communication Services 3.04%
5 Industrials 2.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LXRX icon
3676
Lexicon Pharmaceuticals
LXRX
$1.05B
$32K ﹤0.01%
23,400
+1,900
+9% +$2.16K
SLS icon
3677
SELLAS Life Sciences
SLS
$2.31B
$32K ﹤0.01%
+20,000
New +$35.6K
CLNE icon
3678
Clean Energy Fuels
CLNE
$384M
$31K ﹤0.01%
11,914
-26,321
-69% -$61.6K
OXSQ icon
3679
Oxford Square Capital
OXSQ
$166M
$31K ﹤0.01%
19,322
+183
+1% +$402
WPRT
3680
Westport Fuel Systems
WPRT
$34.6M
$29K ﹤0.01%
12,631
– –
IQ icon
3681
iQIYI
IQ
$1.28B
$28K ﹤0.01%
10,952
-3,177
-22% -$7.03K
CGC
3682
Canopy Growth
CGC
$431M
$27K ﹤0.01%
18,743
+1,817
+11% +$2.36K
HYLN icon
3683
Hyliion Holdings
HYLN
$694M
$25K ﹤0.01%
12,621
+500
+4% +$832
INTZ
3684
Intrusion
INTZ
$15M
$25K ﹤0.01%
15,622
-1,000
-6% -$1.89K
MIST icon
3685
Milestone Pharmaceuticals
MIST
$141M
$25K ﹤0.01%
+12,698
New +$22.3K
QNCX icon
3686
Quince Therapeutics
QNCX
$31.8M
$25K ﹤0.01%
76
– –
SGMO
3687
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$23K ﹤0.01%
34,790
+3,000
+9% +$1.62K
TRIB
3688
Trinity Biotech
TRIB
$7.86M
$23K ﹤0.01%
743
– –
WTI icon
3689
W&T Offshore
WTI
$555M
$23K ﹤0.01%
12,715
– –
TNYA icon
3690
Tenaya Therapeutics
TNYA
$171M
$20K ﹤0.01%
12,186
– –
UAVS icon
3691
AgEagle Aerial Systems
UAVS
$55.5M
$20K ﹤0.01%
+10,000
New +$19.1K
RJET
3692
Republic Airways Holdings
RJET
$962M
$19K ﹤0.01%
999
-67
-6% -$1.18K
MVIS icon
3693
Microvision
MVIS
$111M
$19K ﹤0.01%
1,046
+16
+2% +$286
PRPL icon
3694
Purple Innovation
PRPL
$28.4M
$19K ﹤0.01%
793
– –
ASRT
3695
DELISTED
Assertio
ASRT
$17K ﹤0.01%
1,269
– –
CGEN icon
3696
Compugen
CGEN
$236M
$17K ﹤0.01%
11,250
– –
ZTEK
3697
Zentek
ZTEK
$79.7M
$16K ﹤0.01%
20,500
-1,000
-5% -$880
PACB icon
3698
Pacific Biosciences
PACB
$345M
$15K ﹤0.01%
+11,854
New +$16.1K
CUE icon
3699
Cue Biopharma
CUE
$128M
$14K ﹤0.01%
667
– –
DVLT
3700
Datavault AI
DVLT
$265M
$13K ﹤0.01%
+11,701
New +$6.2K
146 147
148
149 150

Similar funds

TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Royal London Asset Management
Royal London Asset Management United Kingdom $47.7B AUM 29.41% 1-Year Est. Return

Cambridge Investment Research Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Cambridge Investment Research Advisors held 3,908 positions worth $36.4B, up 11% from $32.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors deployed $1.12B of net new capital in Q3 2025, opening 299 new positions and adding to 2,042 existing holdings. Its largest new stake was Scharf ETF: 195,274 shares worth $11M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $27.2M trimmed.

  • Cambridge Investment Research Advisors's largest Q3 2025 buy was Scharf ETF: 195,274 shares worth $11M.
  • Cambridge Investment Research Advisors added most to Vanguard S&P 500 ETF in Q3 2025, an estimated $67.7M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $27.2M.
  • Cambridge Investment Research Advisors fully exited iShares Large Cap Deep Quarterly Laddered ETF in Q3 2025, selling an estimated $8.43M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $36.4B portfolio in Q3 2025.
  • Cambridge Investment Research Advisors opened 299 new positions and closed 193 in Q3 2025.
  • Cambridge Investment Research Advisors's portfolio value rose 11% quarter-over-quarter to $36.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.